Privia Health Group, Inc. (PRVA) Stock Analysis
Healthcare · Health Information Services · NasdaqGS
Privia Health Group, Inc. (PRVA) posted $2.12B in revenue for fiscal 2025 (up 22.3% year over year), at a 1.1% net margin, and has compounded revenue about 21.0%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Privia Health Group, Inc.
Privia Health Group, Inc. has grown revenue from $786.36M to $2.12B over the last 7 fiscal years, compounding about 21% a year. The most recent year was up 22.3%, so growth is actually accelerating.
Net margin sits at 1.1%, up 0.3 points year over year.
At today's valuation the market is pricing in roughly 15.5% annual free-cash-flow growth. The one thing worth a second look in the filings is share count rising (dilution).
Synthesised from Privia Health Group, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
Privia Health Group, Inc. revenue & earnings — last 7 fiscal years
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $786.36M | $817.08M | $966.22M | $1.36B | $1.66B | $1.74B | $2.12B |
| Gross profit | — | — | — | — | — | — | — |
| Net income | $8.24M | $31.24M | $-188.23M | $-8.59M | $23.08M | $14.38M | $22.92M |
| Net margin | 1.0% | 3.8% | -19.5% | -0.6% | 1.4% | 0.8% | 1.1% |
Source: Privia Health Group, Inc. SEC filings (10-K).
Privia Health Group, Inc.: 1 potential red flag in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Share count rising (dilution)Shares outstanding grew 14.6% over 4 years (107.8M → 123.6M) — existing holders' stakes are being diluted.
What growth is priced into PRVA stock?
At today's market cap of $2.87B, Privia Health Group, Inc. is priced for free-cash-flow growth of about 15.5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $80.67M from the FY ending 2023-12-31). For comparison, revenue 21%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 7 years of Privia Health Group, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track PRVA in your portfolio →
Privia Health Group, Inc. financial history by metric
Compare Privia Health Group, Inc. with peers
About Privia Health Group, Inc.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Privia Health Group, Inc. — frequently asked questions
What is Privia Health Group, Inc.'s revenue?
Privia Health Group, Inc. (PRVA) reported revenue of $2.12B for fiscal year 2025, up 22.3% from the prior year, according to its SEC filings.
Is Privia Health Group, Inc. profitable?
Yes. PRVA earned net income of $22.92M in fiscal 2025, a net margin of 1.1%.
What is PRVA's P/E ratio?
Privia Health Group, Inc. trades at a price-to-earnings ratio of about 134.0 based on the latest data in our nightly-refreshed cache.
How fast is Privia Health Group, Inc. growing?
PRVA's revenue grew at roughly 21.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Privia Health Group, Inc. have?
As of fiscal year 2025, PRVA carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Privia Health Group, Inc.'s market cap?
Privia Health Group, Inc. (PRVA) has a market capitalization of about $2.87B, based on the latest data in our nightly-refreshed cache.
When does Privia Health Group, Inc.'s fiscal year end?
PRVA's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into PRVA stock?
At today's market cap of $2.87B, Privia Health Group, Inc. is priced for free-cash-flow growth of about 15.5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $80.67M from the FY ending 2023-12-31). For comparison, revenue 21%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Privia Health Group, Inc.'s official SEC filings (10-K and 10-Q), covering 7 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.